Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.100 | None | 0.962 | 106 | 7 | 1987 | 2020 | ||||||||
|
EWS RNA binding protein 1 | 0.474 | 0.692 | 1.00 |
|
group | 0.100 | None | 0.971 | 69 | 0 | 1993 | 2019 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.966 | 58 | 2 | 1992 | 2019 | ||||||||
|
capicua transcriptional repressor | 0.523 | 0.692 | 1.00 |
|
group | 0.100 | None | 0.972 | 36 | 0 | 2009 | 2020 | ||||||||
|
BCL6 corepressor | 0.471 | 0.808 | 1.00 |
|
group | 0.100 | None | 0.935 | 31 | 0 | 2005 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.100 | None | 0.920 | 25 | 3 | 1990 | 2019 | ||||||||
|
double homeobox 4 | 0.604 | 0.500 |
|
group | 0.100 | None | 0.960 | 25 | 0 | 2009 | 2019 | |||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
group | 0.100 | None | 0.895 | 19 | 1 | 2008 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.100 | None | 1.000 | 17 | 1 | 1995 | 2019 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
group | 0.100 | None | 1.000 | 17 | 0 | 1993 | 2019 | ||||||||
|
cyclin B3 | 0.705 | 0.154 | 0.86 |
|
group | 0.100 | None | 0.938 | 16 | 0 | 2012 | 2020 | ||||||||
|
FUS RNA binding protein | 0.470 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.929 | 14 | 0 | 1996 | 2014 | ||||||||
|
SSX family member 2 | 0.581 | 0.615 |
|
group | 0.100 | None | 1.000 | 13 | 0 | 1998 | 2017 | |||||||||
|
SS18 subunit of BAF chromatin remodeling complex | 0.641 | 0.462 | 0.75 |
|
group | 0.100 | None | 0.923 | 13 | 0 | 1998 | 2017 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
group | 0.100 | None | 1.000 | 13 | 0 | 2003 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.100 | None | 1.000 | 12 | 2 | 2003 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 12 | 2 | 2000 | 2019 | ||||||||
|
synaptotagmin 1 | 0.412 | 0.846 | 0.60 |
|
group | 0.100 | None | 0.909 | 11 | 0 | 1998 | 2017 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
group | 0.100 | None | 1.000 | 11 | 0 | 2014 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.100 | None | 1.000 | 11 | 0 | 1987 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.100 | None | 0.800 | 10 | 2 | 1999 | 2018 | ||||||||
|
SSX family member 2B | 0.599 | 0.577 |
|
group | 0.100 | None | 1.000 | 10 | 0 | 1998 | 2017 | |||||||||
|
dicer 1, ribonuclease III | 0.446 | 0.846 | 1.00 |
|
group | 0.100 | None | 1.000 | 10 | 1 | 2009 | 2020 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.450 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 10 | 0 | 2015 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.100 | None | 1.000 | 10 | 0 | 2007 | 2019 |